Cronos Group Inc.
General ticker "CRON" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.0B (TTM average)
Cronos Group Inc. follows the US Stock Market performance with the rate: 44.8%.
Estimated limits based on current volatility of 1.4%: low 3.11$, high 3.19$
Factors to consider:
- Total employees count: 610 (+32.9%) as of 2025
- Top business risk factors: Limited operating history, Failure to achieve profitability, Strategic risks and growth management, Acquisition/divestiture risks, Product recalls
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.33$, 4.30$]
- 2026-12-31 to 2027-12-31 estimated range: [2.49$, 4.51$]
Financial Metrics affecting the CRON estimates:
- Positive: with PPE of -183.1 at the end of fiscal year the price was low
- Positive: 2.37 < Operating cash flow per share per price, % of 2.49
- Positive: -13.52 < Operating profit margin, % of -10.68
- Positive: -51.61 < Industry operating profit margin (median), % of -17.91
- Positive: -11.23 < Investing cash flow per share per price, % of -7.38
- Positive: -0.55 < Return on assets ratio (scaled to [-100,100]) of -0.24
- Positive: Industry inventory ratio change (median), % of -0.31 <= 0
Short-term CRON quotes
Long-term CRON plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $87.24MM | $117.61MM | $149.15MM |
| Operating Expenses | $172.04MM | $194.14MM | $166.99MM |
| Operating Income | $-84.80MM | $-76.53MM | $-17.84MM |
| Non-Operating Income | $11.13MM | $113.11MM | $0.42MM |
| R&D Expense | $5.84MM | $4.23MM | $4.45MM |
| Income(Loss) | $-73.67MM | $36.59MM | $-17.42MM |
| Taxes | $-3.23MM | $-3.44MM | $-14.44MM |
| Net Income(Loss)* | $-73.96MM | $41.08MM | $-9.61MM |
| Stockholders Equity | $1,099.57MM | $1,064.06MM | $1,093.90MM |
| Inventory | $30.50MM | $33.15MM | $46.75MM |
| Assets | $1,140.27MM | $1,166.31MM | $1,197.14MM |
| Operating Cash Flow | $-42.84MM | $18.84MM | $25.87MM |
| Capital expenditure | $3.42MM | $13.15MM | $26.17MM |
| Investing Cash Flow | $-59.50MM | $175.15MM | $-76.56MM |
| Financing Cash Flow | $-1.03MM | $-1.23MM | $-19.91MM |
| Earnings Per Share** | $-0.19 | $0.11 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.